Maps for peds: development of a microarray patch for delivery of long-acting antiretrovirals for treatment of pediatric HIV infection

Ended Project Grant Awarded Last action

Award ID
R61AI149642
Recipient
Awarding agency
Obligated
$2,350,662

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Funding
  • $1,892,094.00 Federal
  • $458,568.00 Non-federal
Place of performance
Washington, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment -$458,568 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $300,000 $0
Amendment $458,568 $0
Amendment $300,000 $0
Amendment $458,568 $458,568
Amendment $533,526 $0
Original award $300,000 $0
Show all 11

Subawards

Subrecipient Amount Awarded
National Foundation For The Centers For Disease Control & Prevention, Inc. In relation to PATH’s MAPs for Peds: Development of a Microarray Patch for Delivery of Long-Acting Antiretrovirals for Treatment of Pediatric HIV… $386,823
Pharmetheus AB In relation to Microarray patches (MAPs) for Peds: Development of a Microarray Patch for Delivery of Long-Acting Antiretrovirals for Treatment of Pediatric… $232,400
Pharmetheus AB $118,320
The Queen's University Of Belfast Queens University of Belfast, with Professor Ryan Donnelly as co-PI, will develop a MAP containing long-acting antiretrovirals designed to treat pediatric HIV… $1,026,323

Quick answers

Who received award R61AI149642?

R61AI149642 was awarded to Path by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on March 16, 2020.

How much is award R61AI149642 worth?

$2,350,662 has been obligated on R61AI149642: $1,892,094 in federal funding and $458,568 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login